Concert Pharmaceuticals, Inc. Marketable Securities (Current)
Concert Pharmaceuticals, Inc. had Marketable Securities (Current) of $675.00 thousand as of 2022-09-30, per its 10-Q filed 2022-11-07.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2022-11-07
- 2022-09-30: Marketable Securities, Current $675.00K.
- 2022-06-30: Marketable Securities, Current $839.00K.
- 2022-03-31: Marketable Securities, Current $899.00K.
- 2021-12-31: Marketable Securities, Current $1.46M.
| Period end | Marketable Securities, Current |
|---|---|
| 2022-09-30 | $675.00K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $839.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $899.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $1.46M 10-Q · filed 2022-11-07 |
| 2021-09-30 | $2.56M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $2.45M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $3.25M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $1.97M 10-K · filed 2022-03-03 |
| 2020-09-30 | $2.96M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $2.69M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $2.99M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $5.38M 10-K · filed 2021-02-25 |
| 2019-09-30 | $5.43M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $5.10M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $5.23M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $7.53M 10-K · filed 2020-02-27 |
| 2018-09-30 | $9.09M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $9.82M 10-Q · filed 2018-08-02 |
| 2017-12-31 | $0.00 10-K · filed 2019-02-28 |